Page last updated: 2024-12-06

carbaspirin calcium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID21975
CHEMBL ID3833325
MeSH IDM0043788

Synonyms (44)

Synonym
AC-18297
solupsan
carbasalate calcium (inn)
5749-67-7
D03385
carbaspirin calcium (usan)
iromin
carbaspirin calcium
calcium; 2-acetyloxybenzoate; urea
A831468
carbasalate calcium
omegin
unii-n667f17jp1
alcacyl
rheomin
carbaspirin calcium [usan]
n667f17jp1 ,
carbasalato calcico [inn-spanish]
carbasalate calcique [inn-french]
calpirinsan
carbasalate calcium [inn]
carbasalato calcico
carbasalatum calcicum
carbasalate calcique
carbasalatum calcicum [inn-latin]
einecs 227-273-0
carbaspirin calium
carbasalatcalcium
AKOS015895683
carbasalate calcium [mart.]
calcium acetylsalicylate carbamide
calcium carbaspirin
carbasalate calcium [who-dd]
carbasalate calcium [ep monograph]
CHEMBL3833325
DTXSID90206099
AKOS025401461
DB13612
Q2203957
AS-13259
carbasalate?calcium
BCP12255
alcacyl; rheomin; solupsan; omegin
calcium;2-acetyloxybenzoate;urea

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The global incidence of adverse events was 45% higher with EC, though not significant (32 vs."( Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Geraud, G; Gómez, JP; Henry, P; Joffroy, A; Lainez, JM; Le Jeunne, C; Liaño, H; Pradalier, A; Titus i Albareda, F, 1999
)
0.3

Pharmacokinetics

ExcerptReferenceRelevance
" The plasma concentrations of its metabolites, aspirin (ASA), salicylic acid (SA) and gentisic acid (GA) were determined by LC-MS/MS method and the pharmacokinetic parameters were calculated by noncompartmental analysis."( Analytical determination and pharmacokinetics of major metabolites of carbasalate calcium in broilers following oral administration.
Chen, DM; Huang, LL; Ihsan, A; Wang, X; Yuan, ZH, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's4 (28.57)18.2507
2000's5 (35.71)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.01 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies4 (26.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (33.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aspirin AM or PM in Reduction of Tension: a Randomized Cross-over Trial [NCT01379079]Phase 4290 participants (Actual)Interventional2011-04-30Completed
Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation: A Randomised Phase II Clinical Trial [NCT02565693]Phase 2101 participants (Actual)Interventional2014-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]